Mark Baldry

Companies

• X4 Pharmaceuticals, IncChief Commercial Officer Nov 4, 2022 to now¹
• Wave Life SciencesChief Commerical Officer Aug 7, 2019 to Aug 7, 2019²
• Amicus TherapeuticsVP Global Marketing Jun 4, 2015 to Jun 4, 2015³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• XPX4 Pharmaceuticals, Inc XFOR25,337 shares⁴$65.0K at $2.56May 16, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• May 16, 2025Granted 1,032 shares at $2.48 of X4 Pharmaceuticals, Inc⁴
• May 16, 2025Bought 1,032 shares at $2.48 of X4 Pharmaceuticals, Inc⁵
• Feb 12, 2025Granted 600,000 shares of X4 Pharmaceuticals, Inc⁶
• Jan 24, 2025Sold 29,159 shares at $0.45 of X4 Pharmaceuticals, Inc⁷
• Jan 23, 2025Granted 74,773 shares of X4 Pharmaceuticals, Inc⁷
• Nov 15, 2024Bought 13,404 shares at $0.34 of X4 Pharmaceuticals, Inc⁶
• Oct 7, 2024Sold 11,127 shares at $0.58 of X4 Pharmaceuticals, Inc⁸
• Oct 4, 2024Granted 34,946 shares of X4 Pharmaceuticals, Inc⁸
• May 17, 2024Bought 21,646 shares at $0.68 of X4 Pharmaceuticals, Inc⁶
• Nov 1, 2023Sold 10,257 shares at $0.73 of X4 Pharmaceuticals, Inc⁹
• Oct 31, 2023Granted 34,947 shares of X4 Pharmaceuticals, Inc¹⁰